Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
May 4, 2021
A generic framework for the physiologically-based pharmacokinetic platform qualification of PK-Sim and its application to predicting cytochrome P450 3A4-mediated drug-drug interactions
Sebastian Frechen, Juri Solodenko, Thomas Wendl, et al.
Journal of Clinical Pharmacology
|
April 23, 2022
Population Pharmacokinetics of Nifurtimox in Adult and Pediatric Patients With Chagas Disease
Ibrahim Ince, Klaas Prins, Stefan Willmann, et al.
Journal of Clinical Pharmacology
|
September 11, 2019
Predictive Pediatric Modeling and Simulation Using Ontogeny Information
Ibrahim Ince, Juri Solodenko, Sebastian Frechen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 15, 2021
Clinical investigation of the biopharmaceutical characteristics of nifurtimox tablets - Implications for quality control and application
Heino Stass, Sarah Just, Boris Weimann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 17, 2023
Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults - an AGePOP review
Cleo Demeester, Donnia Robins, Angela Elma Edwina, et al.
Therapeutic Drug Monitoring
|
June 5, 2012
Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years
Ibrahim Ince, Saskia N de Wildt, Mariska Y M Peeters, et al.
British Journal of Clinical Pharmacology
|
August 25, 2015
Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds
Amit A Somani, Kirstin Thelen, Songmao Zheng, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 5, 2023
Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for Vericiguat
Sebastian Frechen, Ibrahim Ince, André Dallmann, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 6, 2022
Model-informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease
Stefan Willmann, Ibrahim Ince, Maurice Ahsman, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in Children
Ibrahim Ince, André Dallmann, Sebastian Frechen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
CPT: Pharmacometrics & Systems Pharmacology
|
May 4, 2021
A generic framework for the physiologically-based pharmacokinetic platform qualification of PK-Sim and its application to predicting cytochrome P450 3A4-mediated drug-drug interactions
Sebastian Frechen, Juri Solodenko, Thomas Wendl, et al.
Journal of Clinical Pharmacology
|
April 23, 2022
Population Pharmacokinetics of Nifurtimox in Adult and Pediatric Patients With Chagas Disease
Ibrahim Ince, Klaas Prins, Stefan Willmann, et al.
Journal of Clinical Pharmacology
|
September 11, 2019
Predictive Pediatric Modeling and Simulation Using Ontogeny Information
Ibrahim Ince, Juri Solodenko, Sebastian Frechen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 15, 2021
Clinical investigation of the biopharmaceutical characteristics of nifurtimox tablets - Implications for quality control and application
Heino Stass, Sarah Just, Boris Weimann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 17, 2023
Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults - an AGePOP review
Cleo Demeester, Donnia Robins, Angela Elma Edwina, et al.
Therapeutic Drug Monitoring
|
June 5, 2012
Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years
Ibrahim Ince, Saskia N de Wildt, Mariska Y M Peeters, et al.
British Journal of Clinical Pharmacology
|
August 25, 2015
Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds
Amit A Somani, Kirstin Thelen, Songmao Zheng, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 5, 2023
Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for Vericiguat
Sebastian Frechen, Ibrahim Ince, André Dallmann, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 6, 2022
Model-informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease
Stefan Willmann, Ibrahim Ince, Maurice Ahsman, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in Children
Ibrahim Ince, André Dallmann, Sebastian Frechen, et al.
Page
of 3